month prior to being randomised to DBP: -3(SEM: 3, study one of two treatments: 95%CI: -14.88, of study Low sodium/placebo: Insufficient participants remain baseline data on low sodium diet to calculate and take 10x change in MAP placebo between tablets/day treatments High sodium: participants remain on low sodium diet and take 10x slow sodium tablets per day (total 100mmol/day) Key features for bias assessment of randomised trials Citation Method of Allocation Blinding Loss to Use of Ceasing early Reporting Funding source randomisation concealment for benefit all where outcome required results
study month prior to of study being randomised to one of two treatments: Low sodium/placebo: participants remain on low sodium diet and take 10x placebo tablets/day High sodium: participants remain on low sodium diet and take 10x slow sodium tablets per day (total 100mmol/day) DBP: -3(SEM: 3, 95%CI: -14.88, Insufficient baseline data to calculate change in MAP between treatments Key features for bias assessment of randomised trials Citation Method of randomisation Allocation concealment Blinding Loss to Use of where required Ceasing early for benefit Reporting all outcome results Funding source